FAST NEWS: WuXi AppTec Posts 73% Increase in Earnings, Benefiting from Higher Revenue
The latest: Pharmaceutical services outsourcing company WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) announced Friday its net profit for the first half of 2022 was approximately 4.64 billion yuan ($690 million), representing a year-over-year…
RELATED ARTICLES
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK
-
Potential U.S. targeting casts shadow over WuXi AppTec family
2359.HK 603259.SHG
-
WuXi Bio prescribes share buyback to relieve revenue pain
2269.HK
-
FAST NEWS: JPMorgan boosts WuXi AppTec stake
2359.HK 603259.SHG
-
FAST NEWS: U.S. investment firm boosts WuXi AppTec stake
2359.HK 603259.SHG
-
FAST NEWS: BlackRock boosts stake in battered WuXi AppTec
2359.HK 603259.SHG
- InSilico seeks IPO boost to get AI drugs over the line
Discover hidden China stock gems in our weekly newsletter